A VLP-Based Vaccine Displaying HBHA and MTP Antigens of Mycobacterium tuberculosis Induces Potentially Protective Immune Responses in M. tuberculosis H37Ra Infected Mice
Vaccines · 04.05.2023 · 11 (5) · 941
DOI: 10.3390/vaccines11050941 ↗Kurz gefasst
Fachartikel in der Zeitschrift Vaccines, online erschienen am 04.05.2023. Verfasst von Juan Wang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Gansu Provincial Key Laboratory of Evidence Based Medicine and Clinical Translation, Lanzhou Center for Tuberculosis Research, Institute of Pathogen …. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China, Gansu Science and Technology Project in China, State Key Laboratory of Veterinary Etiological Biology of China.
Abstract (Originalsprache)
Heparin-binding hemagglutinin (HBHA) and M. tuberculosis pili (MTP) are important antigens on the surface of Mycobacterium tuberculosis. To display these antigens effectively, the fusion protein HBHA-MTP with a molecular weight of 20 kD (L20) was inserted into the receptor-binding hemagglutinin (HA) fragment of influenza virus and was expressed along with matrix protein M1 in Sf9 insect cells to generate influenza virus-like particles (LV20 in short). The results showed that the insertion of L20 into the envelope of the influenza virus did not affect the self-assembly and morphology of LV20 VLPs. The expression of L20 was successfully verified by transmission electron microscopy. Importantly, it did not interfere with the immunogenicity reactivity of LV20 VLPs. We demonstrated that LV20 combined with the adjuvant composed of DDA and Poly I: C (DP) elicited significantly higher antigen-specific antibodies and CD4+/CD8+ T cell responses than PBS and BCG vaccination in mice, and reduced the bacterial load in the lungs of mice infected with M. tuberculosis H37Ra. It suggests that the insect cell expression system is an excellent protein production system, and LV20 VLPs could be a novel tuberculosis vaccine candidate for further evaluation.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Gansu Provincial Key Laboratory of Evidence Based Medicine and Clinical Translation, Lanzhou Center for Tuberculosis Research, Institute of Pathogen Biology, School of Basic Medical Sciences, Lanzhou University, Lanzhou…
- Institute of Pathogenic Physiology, School of Basic Medical Sciences, Lanzhou University, Lanzhou 730000, China.
- Respiratory Department of Lanzhou Pulmonary Hospital, Lanzhou 730000, China.
- State Key Laboratory of Genetic Engineering, School of Life Sciences, Fudan University, Shanghai 200438, China.
- Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Lanzhou 730000, China.
- State Key Laboratory for Animal Disease Control and Prevention, College of Veterinary Medicine, Lanzhou University, Lanzhou 730000, China.
ORCID-Profile: Jixi Li, Bingdong Zhu
Förderung
- National Key Research and Development Program of China
- Gansu Science and Technology Project in China
- State Key Laboratory of Veterinary Etiological Biology of China
Zitieren
APA
Wang, J., Xie, T., Ullah, I., Mi, Y., Li, X., Gong, Y., He, P., Liu, Y., Li, F., Li, J., Lu, Z., & Zhu, B. (2023). A VLP-Based Vaccine Displaying HBHA and MTP Antigens of Mycobacterium tuberculosis Induces Potentially Protective Immune Responses in M. tuberculosis H37Ra Infected Mice. Vaccines, 11(5), 941. https://doi.org/10.3390/vaccines11050941
Vancouver
Wang J, Xie T, Ullah I, Mi Y, Li X, Gong Y, et al. A VLP-Based Vaccine Displaying HBHA and MTP Antigens of Mycobacterium tuberculosis Induces Potentially Protective Immune Responses in M. tuberculosis H37Ra Infected Mice. Vaccines. 2023;11(5):941. doi:10.3390/vaccines11050941
BibTeX
@article{Wang2023,
author = {Wang, Juan and Xie, Tao and Ullah, Inayat and Mi, Youjun and Li, Xiaoping and Gong, Yang and He, Pu and Liu, Yuqi and Li, Fei and Li, Jixi and Lu, Zengjun and Zhu, Bingdong},
title = {A VLP-Based Vaccine Displaying HBHA and MTP Antigens of Mycobacterium tuberculosis Induces Potentially Protective Immune Responses in M. tuberculosis H37Ra Infected Mice},
journal = {Vaccines},
year = {2023},
volume = {11},
number = {5},
pages = {941},
doi = {10.3390/vaccines11050941}
}
EUVIMED